These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17667863

  • 1. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM.
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [Abstract] [Full Text] [Related]

  • 2. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
    Frohlich ED.
    J Cardiometab Syndr; 2008 Jun; 3(3):147-8. PubMed ID: 18983330
    [No Abstract] [Full Text] [Related]

  • 3. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM.
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [Abstract] [Full Text] [Related]

  • 4. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA.
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic options for modifying cardiometabolic risk factors.
    Aronne LJ.
    Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
    [Abstract] [Full Text] [Related]

  • 6. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C.
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
    Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS.
    J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
    [Abstract] [Full Text] [Related]

  • 9. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M.
    Gerontology; 2008 Dec; 54(5):253-9. PubMed ID: 18841025
    [Abstract] [Full Text] [Related]

  • 10. Challenges and strategies in managing cardiometabolic risk.
    Repas TB.
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [Abstract] [Full Text] [Related]

  • 11. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
    Jensen MD.
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496
    [Abstract] [Full Text] [Related]

  • 12. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW, Ghushchyan V, Wyatt HR, Hill JO.
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [Abstract] [Full Text] [Related]

  • 13. Obesity: new perspectives and pharmacotherapies.
    Palamara KL, Mogul HR, Peterson SJ, Frishman WH.
    Cardiol Rev; 2006 Dec; 14(5):238-58. PubMed ID: 16924165
    [Abstract] [Full Text] [Related]

  • 14. The cardiometabolic syndrome in the adolescent.
    Gardner M, Gardner DW, Sowers JR.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [Abstract] [Full Text] [Related]

  • 15. Metabolic syndrome: epidemiology and consequences.
    Sacks FM.
    J Clin Psychiatry; 2004 Aug; 65 Suppl 18():3-12. PubMed ID: 15600380
    [Abstract] [Full Text] [Related]

  • 16. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM.
    Am J Cardiol; 2008 Dec 22; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract] [Full Text] [Related]

  • 17. Management of obesity: medical treatment options.
    Carek PJ, Sherer JT, Carson DS.
    Am Fam Physician; 1997 Feb 01; 55(2):551-8, 561-2. PubMed ID: 9054224
    [Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome and cardiovascular disease.
    Qiao Q, Gao W, Zhang L, Nyamdorj R, Tuomilehto J.
    Ann Clin Biochem; 2007 May 01; 44(Pt 3):232-63. PubMed ID: 17456293
    [Abstract] [Full Text] [Related]

  • 19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A, Temizhan A, Abaci A, Kozan O, Erol C, Ongen Z, Celik S.
    Anadolu Kardiyol Derg; 2008 Dec 01; 8(6):401-6. PubMed ID: 19103534
    [Abstract] [Full Text] [Related]

  • 20. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
    Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F, Beya C.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 01; 15(5):503-8. PubMed ID: 18830083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.